Torley Helen Insider Trading -- Recent SEC Form 4 Transactions
Torley Helen (CIK 1528185) reported 175 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-10-08). Recent activity: Buy HALO (20,000 shares), Sell HALO (200 shares), Sell HALO (6,000 shares), Sell HALO (9,920 shares), Sell HALO (1,780 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-10-08 | HALOZYME THERAPEUTICS, INC. (HALO) | PRESIDENT AND CEO | Buy | 20,000 | $368,200 |
| 2026-10-08 | HALOZYME THERAPEUTICS, INC. (HALO) | PRESIDENT AND CEO | Sell | 200 | $22,102 |
| 2026-10-08 | HALOZYME THERAPEUTICS, INC. (HALO) | PRESIDENT AND CEO | Sell | 6,000 | $656,004 |
| 2026-10-08 | HALOZYME THERAPEUTICS, INC. (HALO) | PRESIDENT AND CEO | Sell | 9,920 | $1.1M |
| 2026-10-08 | HALOZYME THERAPEUTICS, INC. (HALO) | PRESIDENT AND CEO | Sell | 1,780 | $197,245 |
| 2026-10-08 | HALOZYME THERAPEUTICS, INC. (HALO) | PRESIDENT AND CEO | Buy | 20,000 | $368,200 |
| 2026-10-08 | HALOZYME THERAPEUTICS, INC. (HALO) | PRESIDENT AND CEO | Sell | 8,600 | $954,867 |
| 2026-10-08 | HALOZYME THERAPEUTICS, INC. (HALO) | PRESIDENT AND CEO | Sell | 2,300 | $248,175 |
| 2026-10-08 | HALOZYME THERAPEUTICS, INC. (HALO) | PRESIDENT AND CEO | Sell | 900 | $101,502 |
| 2026-10-08 | HALOZYME THERAPEUTICS, INC. (HALO) | PRESIDENT AND CEO | Sell | 200 | $22,739 |
| 2026-10-08 | HALOZYME THERAPEUTICS, INC. (HALO) | PRESIDENT AND CEO | Buy | 20,000 | $368,200 |
| 2026-10-08 | HALOZYME THERAPEUTICS, INC. (HALO) | PRESIDENT AND CEO | Sell | 4,810 | $520,341 |
| 2026-10-08 | HALOZYME THERAPEUTICS, INC. (HALO) | PRESIDENT AND CEO | Sell | 3,090 | $336,526 |
| 2026-10-08 | HALOZYME THERAPEUTICS, INC. (HALO) | PRESIDENT AND CEO | Sell | 11,900 | $1.3M |
| 2026-10-08 | HALOZYME THERAPEUTICS, INC. (HALO) | PRESIDENT AND CEO | Sell | 10,300 | $1.2M |
| 2026-09-11 | HALOZYME THERAPEUTICS, INC. (HALO) | PRESIDENT AND CEO | Buy | 20,000 | $368,200 |
| 2026-09-11 | HALOZYME THERAPEUTICS, INC. (HALO) | PRESIDENT AND CEO | Sell | 13,304 | $1.4M |
| 2026-09-11 | HALOZYME THERAPEUTICS, INC. (HALO) | PRESIDENT AND CEO | Sell | 6,596 | $711,187 |
| 2026-09-11 | HALOZYME THERAPEUTICS, INC. (HALO) | PRESIDENT AND CEO | Sell | 100 | $10,867 |
| 2026-09-11 | HALOZYME THERAPEUTICS, INC. (HALO) | PRESIDENT AND CEO | Sell | 4,508 | $484,826 |
| 2026-09-11 | HALOZYME THERAPEUTICS, INC. (HALO) | PRESIDENT AND CEO | Sell | 14,588 | $1.6M |
| 2026-09-11 | HALOZYME THERAPEUTICS, INC. (HALO) | PRESIDENT AND CEO | Sell | 5,412 | $582,228 |
| 2026-09-11 | HALOZYME THERAPEUTICS, INC. (HALO) | PRESIDENT AND CEO | Buy | 20,000 | $368,200 |
| 2026-09-11 | HALOZYME THERAPEUTICS, INC. (HALO) | PRESIDENT AND CEO | Sell | 15,492 | $1.7M |
| 2026-09-11 | HALOZYME THERAPEUTICS, INC. (HALO) | PRESIDENT AND CEO | Buy | 20,000 | $368,200 |
Source: SEC Form 4 filings · as of 2026-10-08